Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment

Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment

PurposeThis study aims to assess the prognostic value of inflammatory markers and clinical features in advanced or metastatic esophageal squamous cell carcinoma (ESCC) patients receiving anti-programmed death 1 (PD-1) treatment.MethodsBased on receiver operating characteristic curve (ROC) analysis,...

Полное описание

Библиографические подробности
Главные авторы: Liangshan Da, Ziting Qu, Congjun Zhang, Yuanyuan Shen, Wei Huang, Yiyin Zhang, Kangsheng Gu
Формат: Статья
Язык:English
Опубликовано: Frontiers Media S.A. 2023-03-01
Серии:Frontiers in Oncology
Предметы:
esophageal squamous cell carcinoma
PD-1
inflammatory markers
prognosis
immunotherapy
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fonc.2023.1144875/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1144875/full

Схожие документы